Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 345 of the 345 references it cites were found in a registry or an index.

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities

Open access
Liu, Jiaqi, Xiao, Qing, Xiao, Jiani, Niu, Chenxi, Li, Yuanyuan, Zhang, Xiaojun, Zhou, Zhengwei, Shu, Guang, Yin, Gang · 2022 · Signal Transduction and Targeted Therapy

Abstract

The Wnt/β-catenin pathway comprises a family of proteins that play critical roles in embryonic development and adult tissue homeostasis. The deregulation of Wnt/β-catenin signalling often leads to various serious diseases, including cancer and non-cancer diseases. Although many articles have reviewed Wnt/β-catenin from various aspects, a systematic review encompassing the origin, composition, function, and clinical trials of the Wnt/β-catenin signalling pathway in tumour and diseases is lacking. In this article, we comprehensively review the Wnt/β-catenin pathway from the above five aspects in combination with the latest research. Finally, we propose challenges and opportunities for the development of small-molecular compounds targeting the Wnt signalling pathway in disease treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41392-021-00762-6

Cites

345 of 345 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Wnt/β-catenin pathway. Left (inactivation of Wnt signalling): In the absence of Wnt signalling, β-catenin is degraded by protein complexes, including AXIN, APC, serine/threonine kinase GSK-3, and CK1 and E3 ubiquitin ligase β-trcp. Right (activation of Wnt signalling): Wnt signalling is activated by binding to its receptor, which induces the binding of AXIN to phosphorylated lipoprotein receptor-related protein (LRP). The destruction complex is broken, and then β-catenin stabilizes and binds to TCF in the nucleus to regulate the target gene. GSK-3 glycogen synthase kinase-3, AXIN axis inhibition protein, CK1 casein kinase 1, APC adenomatous polyposis coli, TCF T cell factor, LEF lymphocyte enhancer factor-1
Fig. 1 Wnt/β-catenin pathway. Left (inactivation of Wnt signalling): In the absence of Wnt signalling, β-catenin is degraded by protein complexes, including AXIN, APC, serine/threonine kinase GSK-3, and CK1 and E3 ubiquitin ligase β-trcp. Right (activation of Wnt signalling): Wnt signalling is activated by binding to its receptor, which induces the binding of AXIN to phosphorylated lipoprotein receptor-related protein (LRP). The destruction complex is broken, and then β-catenin stabilizes and binds to TCF in the nucleus to regulate the target gene. GSK-3 glycogen synthase kinase-3, AXIN axis inhibition protein, CK1 casein kinase 1, APC adenomatous polyposis coli, TCF T cell factor, LEF lymphocyte enhancer factor-1CC BY · PubMed Central
Fig. 2 Inhibitors and activators of the Wnt/β-catenin pathway. A Inhibitors of the Wnt/β-catenin signalling pathway. sFRPs, WIF, Tiki, and Notum are located outside the plasma membrane and inhibit Wnt signal transduction by interacting with Wnts. FZD, LRP5/6, RNF43/ZNRF3, Krem-1/2, ROR, RYK, and glypican are located on the plasma membrane. RNF43/ZNRF3 binds to the FZD receptor complex and induces its ubiquitination and endocytosis. ROR, RYK, and glypican bind to Wnts and inhibit Wnt signal transduction. DKK1/3/4 binds to LRP5/6 or further forms a complex with Krem-1/2 to induce endocytosis. Groucho is located in the nucleus and inhibits the transcription of target genes by binding to LEF. B Activators of the Wnt/β-catenin signalling pathway. R-spondin and Norrin are located outside the plasma membrane. FZD, LRP5/6, RNF43/ZNRF3, and LGR4/5 are located on the plasma membrane. The β-catenin destruction complex (comprising axin, APC, GSK-3β, CK-1α, and β-catenin) and PP2A are located in the cytoplasm. TCF/LEF is located in the nucleus. Association of LGR4/5 and RNF43/ZNRF3 with R-spondin induces membrane retention of FZD. Norrin activates signal transduction by acting as a mimic of Wnts. PP2A dephosphorylates β-catenin to promote the accumulation of β-catenin in the cytoplasm. Β-catenin enters the nucleus and combines with TCF/LEF to initiate the transcription of target genes. DKK Dickkopf, WIF Wnt inhibitory factor, CRD cysteine-rich domain, LRP lipoprotein receptor-related protein, RNF ring finger protein
Fig. 2 Inhibitors and activators of the Wnt/β-catenin pathway. A Inhibitors of the Wnt/β-catenin signalling pathway. sFRPs, WIF, Tiki, and Notum are located outside the plasma membrane and inhibit Wnt signal transduction by interacting with Wnts. FZD, LRP5/6, RNF43/ZNRF3, Krem-1/2, ROR, RYK, and glypican are located on the plasma membrane. RNF43/ZNRF3 binds to the FZD receptor complex and induces its ubiquitination and endocytosis. ROR, RYK, and glypican bind to Wnts and inhibit Wnt signal transduction. DKK1/3/4 binds to LRP5/6 or further forms a complex with Krem-1/2 to induce endocytosis. Groucho is located in the nucleus and inhibits the transcription of target genes by binding to LEF. B Activators of the Wnt/β-catenin signalling pathway. R-spondin and Norrin are located outside the plasma membrane. FZD, LRP5/6, RNF43/ZNRF3, and LGR4/5 are located on the plasma membrane. The β-catenin destruction complex (comprising axin, APC, GSK-3β, CK-1α, and β-catenin) and PP2A are located in the cytoplasm. TCF/LEF is located in the nucleus. Association of LGR4/5 and RNF43/ZNRF3 with R-spondin induces membrane retention of FZD. Norrin activates signal transduction by acting as a mimic of Wnts. PP2A dephosphorylates β-catenin to promote the accumulation of β-catenin in the cytoplasm. Β-catenin enters the nucleus and combines with TCF/LEF to initiate the transcription of target genes. DKK Dickkopf, WIF Wnt inhibitory factor, CRD cysteine-rich domain, LRP lipoprotein receptor-related protein, RNF ring finger proteinCC BY · PubMed Central
Fig. 3 Wnt/β-catenin pathway and non-cancer diseases. Dysregulation of the Wnt/β-catenin pathway is involved in lung diseases, heart diseases, liver diseases, hair diseases, bone diseases, and nervous diseases. MI myocardial infarction, COPD chronic obstructive pulmonary disease, IPF idiopathic pulmonary fibrosis, BPD bronchopulmonary dysplasia, AIH autoimmune hepatitis
Fig. 3 Wnt/β-catenin pathway and non-cancer diseases. Dysregulation of the Wnt/β-catenin pathway is involved in lung diseases, heart diseases, liver diseases, hair diseases, bone diseases, and nervous diseases. MI myocardial infarction, COPD chronic obstructive pulmonary disease, IPF idiopathic pulmonary fibrosis, BPD bronchopulmonary dysplasia, AIH autoimmune hepatitisCC BY · PubMed Central
Fig. 4 Canonical Wnt signalling pathway and pharmacological inhibitors under investigation in cancer
Fig. 4 Canonical Wnt signalling pathway and pharmacological inhibitors under investigation in cancerCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

4 retracted

Show all 345 references

Research works printed but not linked: 8

  1. Amemiya, T., Tsuboi, M. & Uchida, S. Electron microscopic and electron histochemical studies on embryonal rhabdomyosarcoma of the orbit. Zeitschrift fur Krebsforschung und klinische. Onkol. Cancer Res. Clin. Oncol. 83, 305–314 (1975).
  2. Cruciat, C. M. & Niehrs, C. Secreted and transmembrane wnt inhibitors and activators[J]. Cold Spring Harb. Perspect. Biol. 5, a015081 (2013). · DOI · Paper page
  3. Malinauskas, T. et al. Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1[J]. Nat. Struct. Mol. Biol. 18, 886–893 (2011). · DOI · Paper page
  4. Jiang, X. et al. Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases[J]. Mol. Cell 58, 522–533 (2015). · DOI · Paper page
  5. Kwon, C. et al. Notch post-translationally regulates β-catenin protein in stem and progenitor cells[J]. Nat. cell Biol. 13, 1244–1251 (2011). · DOI · Paper page
  6. Jimeno, A. et al. A First-in-Human Phase I Study of the Anticancer Stem Cell Agent Ipafricept (OMP-54F28), a Decoy Receptor for Wnt Ligands, in Patients with Advanced Solid Tumors. Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res. 23, 7490–7497 (2017). · DOI · Paper page
  7. Arensman, M. et al. The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth. Mol. cancer therapeutics 13, 2303–2314 (2014). · DOI
  8. Emami, K. et al. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc. Natl Acad. Sci. USA 101, 12682–12687 (2004). · DOI · Paper page

Cited by

See all 2,519

Metadata

Authors
Liu, J., Xiao, Q., Xiao, J., Niu, C., Li, Y., Zhang, X., Zhou, Z., Shu, G., & Yin, G.
Affiliations
Central South University (CN)
Corresponding author
Yin, Gang
Venue
Signal Transduction and Targeted Therapy
Published
2022-01-03
Volume
7
Issue
1
Pages
3-3
ISSN
2059-3635 (ISSN-L)
OpenAlex
W4205498896
Cited by
2,519
References
345
Citations by year
2026: 571 · 2025: 859 · 2024: 704 · 2023: 317 · 2022: 65
FWCI
50.68
Type
journal article
Language
en
Open access
Licence
Locations
  • Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
Keywords
Wnt/β-catenin signaling, Wnt proteins, β-catenin, embryonic development, tissue homeostasis, cancer, non-cancer diseases, small molecule inhibitors, therapeutic target, clinical trials
MeSH terms
Animals, Humans, Neoplasm Proteins, Neoplasms, Wnt Proteins, beta Catenin, Wnt Signaling Pathway

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. https://app.cochat.ai/papers/10.1038/s41392-021-00762-6
The paper
Liu, J., Xiao, Q., Xiao, J., Niu, C., Li, Y., Zhang, X., Zhou, Z., Shu, G., & Yin, G. (2022). Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-021-00762-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.